Patients receiving oral anti-cancer medicines Other
Conditions
Interventions
Consenting participants will receive their prescribed OACM in its standard manufacturer packaging, but contained within the PharmaBag over-packing system. They will receive written instructions outlin
all medications will continue to be dispensed according to the participant’s usual treatment plan. The additional packaging will enable quality assurance checks to support information on the reusabili
Sponsors
Clatterbridge Cancer Centre NHS Foundation Trust
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Adults aged =18 years 2. Diagnosis of cancer 3. Prescribed oral anti-cancer medicines (OACMs) by clinicians at The Clatterbridge Cancer Centre 4. Able to provide informed consent
Exclusion criteria
Exclusion criteria: Severe co-morbidities considered by the study team to interfere with the individual's ability to complete requirements of the study, or to provide informed consent.
Countries
England, United Kingdom
Contacts
Public ContactSeamus Coyle
Outcome results
None listed